In a report released today, Mark Mahaney from Evercore ISI maintained a Buy rating on Ibotta, Inc. Class A (IBTA – Research Report), with ...

Evercore ISI analyst Liisa Bayko maintained a Buy rating on Innate Pharma (IPHA – Research Report) today and set a price target of $5.00.

Sarah Bianchi, Evercore ISI chief strategist of public policy, joins CNBC's 'The Exchange' to discuss the so-called DOGE ...

Capri and Tapestry have mutually agreed to terminate their planned merger. Capri CEO continues to see long-term potential in ...

Krishna Guha, Evercore ISI vice chairman, joins CNBC's 'Squawk Box' to discuss expectations for PPI, how a new Trump ...

Investing.com - A "strong case" can be made for a re-valuation higher of the life insurance sector, according to analysts at ...

Evercore ISI initiates negative call on Target Corporation (TGT) ahead of earnings report, forecasting Q3 sales deceleration ...

Evercore ISI revised its ratings for several industrial and machinery stocks following the US election results, citing a more optimistic business outlook tied to the anticipated "pro-business Trump" ...

‘Trump trades’ move into overdrive as Dow, dollar and bond yields soar. What’s next for markets. Wall Street believes stocks will keep climbing on Trump victory — but here’s what could potentially ...

The S&P 500 is poised for continued growth into mid-2025 after Trump's victory: Evercore ISI The stock-market rally still has room to run, as Donald Trump's stunning comeback for the White House and a ...

The US stocks rally is nowhere near done, according to Evercore ISI strategists, who see Donald Trump’s plans to slice through red tape propelling the S&P 500 Index another 11% through the middle of ...

We recently compiled a list of the 10 AI News You Shouldn’t Miss. In this article, we are going to take a look at where ...